Global ADME Toxicology Testing Market Report and Forecast 2025-2034

ADME Toxicology Testing Market Overview

ADME toxicology testing analyzes the absorption, distribution, metabolism, and excretion of a drug, therefore judging the safety profile of that drug. Studies in such cases investigate possible toxic effects so that drug developers produce safer drugs. In the entire process of drug discovery, the demand for drugs is increasing at a very rapid rate. These tests, therefore, ensure that the drugs are safe and effective for use in humans. This demand, especially in the preclinical stages of drug development, is pushing the market for cheaper, more efficient, and more reliable testing in toxicology.

ADME Toxicology Testing Market Growth Drivers

Technological Advancements and Increased Demand for Safer Drug Development to Boost the Market Value

Due to the rapid technological advancements and growing demand for safer drug development, the global market for ADME toxicology testing is growing at an expedited rate. For instance, in September 2024, Emulate Inc. launched Chip-R1 Rigid Chip, an Organ-on-a-Chip model that reduces drug absorption for better accuracy in the tests. The increasing demand for in vitro testing combined with the decreased toxicity of the drug upon administration further drives the market.

ADME Toxicology Testing Market Trends

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

ADME Toxicology Testing Market Segmentation

ADME Toxicology Testing Market Share

Segmentation Based on Application to Witness Substantial Growth

Based on the application, the market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. Hepatotoxicity is expected to hold a major share in the market. Liver toxicity has been a significant concern in the drug development process as several drugs have been identified to cause liver damage. The high incidence rate of adverse effects related to the liver is expected to drive the market for hepatotoxicity testing in the forecast period.

ADME Toxicology Testing Market Analysis by Region

The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is a leading market share holder due to the high development of the healthcare infrastructure, significant investment in pharmaceutical R&D, and strict regulatory standards. Europe follows closely based on research capabilities, drug development activities, and regulatory pressure for the safety of drugs.

Leading Players in the ADME Toxicology Testing Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is among the global market leaders for ADME toxicology testing. Founded in 1956, the company’s headquarters is in Waltham, Massachusetts. Some of its leading products include Gibco hepatocytes, transporters, and many more ADME/Tox assays that have been used to fast-track drug discovery by allowing reliable in vitro models of liver function, toxicity, and metabolic processes.

Charles River Laboratories

Charles River Laboratories, a Delaware corporation incorporated in 1947 and has its headquarters ...

Eurofins Scientific

Eurofins was established in 1997, with its headquarters based in St. Charles, Missouri, and is a ...

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories is headquartered in Hercules, California, and was established in 1952. It is...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Covance (Labcorp Drug Development), Sekisui XenoTech, LLC, Cyprotex (An Evotec Company), Promega Corporation, Agilent Technologies, Inc., and GE Healthcare (Cytiva).

Key Questions Answered in the ADME Toxicology Testing Market Report

• What was the ADME toxicology testing market value in 2024?
• What is the ADME toxicology testing market forecast outlook for 2025-2034?
• What are the regional markets covered in the EMR report?
• What is the market segmentation based on technology?
• What is the market segmentation based on the method?
• What is the market breakup based on application?
• What is the market breakup based on the end user?
• What major factors aid the ADME toxicology testing market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the major drivers, opportunities, and restraints in the market?
• What are the major trends influencing the market?
• Which regional market is expected to dominate the market share in the forecast period?
• Which country is likely to experience elevated growth during the forecast period?
• Who are the key players involved in the ADME toxicology testing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?